Brief: Aptinyx Announces Publication Of Review Article Highlighting Preclinical Data Demonstrating Potential Of NYX-2925
19/01/2021 14:33
Jan 19 (Reuters) - Aptinyx Inc APTX.O :
* APTINYX ANNOUNCES PUBLICATION OF REVIEW ARTICLE
HIGHLIGHTING
PRECLINICAL DATA IN MEDICINE IN DRUG DISCOVERY DEMONSTRATING
POTENTIAL OF NYX-2925 TO TREAT CHRONIC, CENTRALIZED PAIN
CONDITIONS
Source text for Eikon: ID:nBw7M5SS3a
Further company coverage: APTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aptinyx
See all newsBrief: Aptinyx Gets Notice Of Delisting Or Failure To Satisfy Continued Listing Rule From Nasdaq
Brief: Aptinyx Inc reports On May 4, Board Deemed It In Best Interests Of Co And Its Stockholders That Co Be Dissolved
Aptinyx Inc reports results for the quarter ended in December - Earnings Summary
Brief: Aptinyx Inc Reports Quarterly Loss Per Share Of $0.18
Aptinyx Inc expected to post a loss of 19 cents a share - Earnings Preview